Telpha-Trio
Composition: Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg
Telpha Trio is a powerful triple-drug combination used for the treatment of severe and resistant hypertension. This formulation combines the vascular protection of Telmisartan, smooth BP reduction of Cilnidipine, and the fluid-reducing action of Chlorthalidone. It is highly effective in patients requiring aggressive BP control.
Uses:
- Severe and resistant hypertension
- Patients not controlled with dual therapy
- Reduces heart attack and stroke risk
- Manages fluid retention with strong BP control
Side Effects:
- Dizziness
- Frequent urination
- Low potassium
- Fatigue
- Mild ankle swelling
Other Details:
- Once-daily dosing
- Electrolyte and kidney monitoring required
- Best suited for high-risk hypertensive patients
- Avoid dehydration
